ENGN
Price
$7.75
Change
-$0.39 (-4.79%)
Updated
Oct 3 closing price
Capitalization
416.7M
FOLD
Price
$8.20
Change
-$0.05 (-0.61%)
Updated
Oct 3 closing price
Capitalization
2.54B
32 days until earnings call
Interact to see
Advertisement

ENGN vs FOLD

Header iconENGN vs FOLD Comparison
Open Charts ENGN vs FOLDBanner chart's image
enGene Holdings
Price$7.75
Change-$0.39 (-4.79%)
Volume$80.47K
Capitalization416.7M
Amicus Therapeutics
Price$8.20
Change-$0.05 (-0.61%)
Volume$6.6M
Capitalization2.54B
ENGN vs FOLD Comparison Chart in %
ENGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENGN vs. FOLD commentary
Oct 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENGN is a Hold and FOLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 04, 2025
Stock price -- (ENGN: $7.75 vs. FOLD: $8.20)
Brand notoriety: ENGN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENGN: 38% vs. FOLD: 132%
Market capitalization -- ENGN: $416.7M vs. FOLD: $2.54B
ENGN [@Biotechnology] is valued at $416.7M. FOLD’s [@Biotechnology] market capitalization is $2.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENGN’s FA Score shows that 1 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • ENGN’s FA Score: 1 green, 4 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, ENGN is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENGN’s TA Score shows that 3 TA indicator(s) are bullish while FOLD’s TA Score has 3 bullish TA indicator(s).

  • ENGN’s TA Score: 3 bullish, 4 bearish.
  • FOLD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ENGN is a better buy in the short-term than FOLD.

Price Growth

ENGN (@Biotechnology) experienced а +19.41% price change this week, while FOLD (@Biotechnology) price change was -0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

FOLD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($2.54B) has a higher market cap than ENGN($417M). ENGN YTD gains are higher at: 16.541 vs. FOLD (-12.951). FOLD has higher annual earnings (EBITDA): 33.1M vs. ENGN (-76.26M). FOLD has more cash in the bank: 231M vs. ENGN (217M). ENGN has less debt than FOLD: ENGN (25.4M) vs FOLD (443M). FOLD has higher revenues than ENGN: FOLD (571M) vs ENGN (0).
ENGNFOLDENGN / FOLD
Capitalization417M2.54B16%
EBITDA-76.26M33.1M-230%
Gain YTD16.541-12.951-128%
P/E RatioN/AN/A-
Revenue0571M-
Total Cash217M231M94%
Total Debt25.4M443M6%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENGNFOLD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 24 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ENGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSAQX82.27N/A
N/A
State Street US Core Equity Fund
VMSGX23.46N/A
N/A
VALIC Company I Mid Cap Strategic Gr
TFOAX82.61N/A
N/A
Touchstone Focused A
KSOCX149.10N/A
N/A
Kinetics Small Cap Opportunities Adv C
TMIRX10.80N/A
N/A
Transamerica Mid Cap Growth R

ENGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENGN has been loosely correlated with COGT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ENGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENGN
1D Price
Change %
ENGN100%
-4.79%
COGT - ENGN
48%
Loosely correlated
+6.85%
TELO - ENGN
30%
Poorly correlated
+0.72%
ATHE - ENGN
29%
Poorly correlated
+1.43%
FOLD - ENGN
28%
Poorly correlated
-0.61%
PBYI - ENGN
25%
Poorly correlated
-1.72%
More